PubMed

A phase III, placebo controlled clinical trial of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Hwang DG, Schanzlin DJ, Rotberg MH, Foulks G, Raizman MB; Levofloxacin Bacterial Conjunctivitis Place-controlled Study Group.

Br J Ophthalmol. 2003 Aug;87(8):1004-9.PMID: 12881345 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.

Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT; Levofloxacin Bacterial Conjunctivitis Active Control Study Group.

Ophthalmology. 2003 Mar;110(3):457-65.PMID: 12623805 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of 0.5% levofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis in pediatric patients.

Lichtenstein SJ, Rinehart M; Levofloxacin Bacterial Conjunctivitis Study Group.

J AAPOS. 2003 Oct;7(5):317-24.PMID: 14566313 [PubMed - indexed for MEDLINE]Related articles

Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.

Abelson MB, Heller W, Shapiro AM, Si E, Hsu P, Bowman LM; AzaSite Clinical Study Group.

Am J Ophthalmol. 2008 Jun;145(6):959-65. Epub 2008 Mar 28.PMID: 18374301 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.

McDonald MB, Protzko EE, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL, Usner DW.

Ophthalmology. 2009 Sep;116(9):1615-1623.e1. Epub 2009 Jul 29.PMID: 19643483 [PubMed - indexed for MEDLINE]Related articles

Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis.

Szaflik J, Szaflik JP, Kaminska A; Levofloxacin Bacterial Conjunctivitis Dosage Study Group.

Eur J Ophthalmol. 2009 Jan-Feb;19(1):1-9.PMID: 19123142 [PubMed - indexed for MEDLINE]Related articles

Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.

Karpecki P, Depaolis M, Hunter JA, White EM, Rigel L, Brunner LS, Usner DW, Paterno MR, Comstock TL.

Clin Ther. 2009 Mar;31(3):514-26.PMID: 19393842 [PubMed - indexed for MEDLINE]Related articles

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis.

Tepedino ME, Heller WH, Usner DW, Brunner LS, Morris TW, Haas W, Paterno MR, Comstock TL.

Curr Med Res Opin. 2009 May;25(5):1159-69.PMID: 19323612 [PubMed - indexed for MEDLINE]Related articles

Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.

Tabbara KF, El-Sheikh HF, Islam SM, Hammouda E.

Eur J Ophthalmol. 1999 Oct-Dec;9(4):269-75.PMID: 10651190 [PubMed - indexed for MEDLINE]Related articles

Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis.

Protzko E, Bowman L, Abelson M, Shapiro A; AzaSite Clinical Study Group.

Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3425-9.PMID: 17652708 [PubMed - indexed for MEDLINE]Related articlesFree article

3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.

Cochereau I, Meddeb-Ouertani A, Khairallah M, Amraoui A, Zaghloul K, Pop M, Delval L, Pouliquen P, Tandon R, Garg P, Goldschmidt P, Bourcier T.

Br J Ophthalmol. 2007 Apr;91(4):465-9. Epub 2006 Oct 18.PMID: 17050578 [PubMed - indexed for MEDLINE]Related articles

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.

Abelson MB, Torkildsen GL, Williams JI, Gow JA, Gomes PJ, McNamara TR; Bepotastine Besilate Ophthalmic Solutions Clinical Study Group.

Clin Ther. 2009 Sep;31(9):1908-21.PMID: 19843481 [PubMed - in process]Related articles

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.

Crampton HJ.

Clin Ther. 2003 Jul;25(7):1975-87.PMID: 12946545 [PubMed - indexed for MEDLINE]Related articles

A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis.

Yee RW, Tepedino M, Bernstein P, Jensen H, Schiffman R, Whitcup SM; Gatifloxacin BID/QID Study Group.

Curr Med Res Opin. 2005 Mar;21(3):425-31.PMID: 15811211 [PubMed - indexed for MEDLINE]Related articles

A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.

Kernt K, Martinez MA, Bertin D, Stroman D, Cupp G, Martínez C, Tirado M, Guasch J; International Tobrex2x Group (Eu).

Eur J Ophthalmol. 2005 Sep-Oct;15(5):541-9.PMID: 16167284 [PubMed - indexed for MEDLINE]Related articles

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

Spangler DL, Abelson MB, Ober A, Gotnes PJ.

Clin Ther. 2003 Aug;25(8):2245-67.PMID: 14512132 [PubMed - indexed for MEDLINE]Related articles

A multicenter, randomized, double-blind, retrospective comparison of 5- and 10-day regimens of levofloxacin in a subgroup of patients aged > or =65 years with community-acquired pneumonia.

Shorr AF, Zadeikis N, Xiang JX, Tennenberg AM, Wes Ely E.

Clin Ther. 2005 Aug;27(8):1251-9.PMID: 16199249 [PubMed - indexed for MEDLINE]Related articles

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J.

Urology. 2003 Oct;62(4):614-7.PMID: 14550427 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis.

Jauch A, Fsadni M, Gamba G.

Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):705-13.PMID: 10447643 [PubMed - indexed for MEDLINE]Related articles

Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.

Abelson MB, Berdy GJ, Mundorf T, Amdahl LD, Graves AL; Pemirolast study group.

J Ocul Pharmacol Ther. 2002 Oct;18(5):475-88.PMID: 12419098 [PubMed - indexed for MEDLINE]Related articles